Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $508.68 Consensus Target Price from Brokerages

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned a consensus rating of “Moderate Buy” from the thirty-one analysts that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and twenty-two have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $508.6830.

A number of brokerages have recently commented on ISRG. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, August 14th. KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Royal Bank Of Canada lowered their target price on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a report on Monday, July 13th. Stifel Nicolaus lowered their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a report on Friday, July 17th. Finally, Bank of America dropped their target price on Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th.

Intuitive Surgical Trading Up 2.1%

Shares of NASDAQ ISRG opened at $401.65 on Friday. The stock has a 50-day moving average price of $372.58 and a two-hundred day moving average price of $418.49. The company has a market cap of $141.89 billion, a price-to-earnings ratio of 46.01, a PEG ratio of 2.97 and a beta of 1.47. Intuitive Surgical has a 12 month low of $328.57 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.81 EPS. On average, sell-side analysts predict that Intuitive Surgical will post 8.87 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 400 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the director directly owned 251 shares in the company, valued at $95,129. This trade represents a 61.44% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the sale, the executive vice president directly owned 881 shares in the company, valued at $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,370 shares of company stock valued at $4,891,989 over the last three months. Insiders own 0.60% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors have recently modified their holdings of ISRG. State Street Corp grew its position in shares of Intuitive Surgical by 1.0% in the 4th quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock valued at $8,892,753,000 after buying an additional 162,264 shares during the last quarter. Capital World Investors raised its position in shares of Intuitive Surgical by 1.7% during the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock worth $4,449,491,000 after acquiring an additional 127,526 shares during the last quarter. Norges Bank acquired a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $2,856,987,000. Invesco Ltd. lifted its stake in shares of Intuitive Surgical by 17.4% in the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock worth $2,338,350,000 after acquiring an additional 611,268 shares during the period. Finally, Bank of America Corp DE boosted its holdings in Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after acquiring an additional 116,292 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.